PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y revenue/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-92.21%
Negative 10Y OCF/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-92.21%
Negative 5Y OCF/share CAGR while SMR.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-92.21%
Negative 3Y OCF/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-466.79%
Negative 10Y net income/share CAGR while SMR.AX is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-466.79%
Negative 5Y net income/share CAGR while SMR.AX is 100.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-466.79%
Negative 3Y CAGR while SMR.AX is 100.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-76.40%
Negative equity/share CAGR over 10 years while SMR.AX stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-76.40%
Negative 5Y equity/share growth while SMR.AX is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-76.40%
Negative 3Y equity/share growth while SMR.AX is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.